Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: Results from a double-blind, vehicle-controlled, randomized study

British Journal of Dermatology

Volumn 153, Issue 3, 2005, Pages 626-634

  Holzer, Gregor ^a   Riegler, E ^a   Honigsmann H ^a   Farokhnia, S ^b   Schmidt, B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Ageing; Hydration; Progesterone; Randomized controlled trial; Skin elasticity; Skin lipids

Indexed keywords

ESTROGEN; FOLLITROPIN; LIPID; LUTEINIZING HORMONE; PLACEBO; PROGESTERONE; ULTRABAS; ULTRASICC;

ADULT; AGING; ARTICLE; BURNING SENSATION; CLIMACTERIUM; CLINICAL TRIAL; COMEDO; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ELASTICITY; EPIDERMIS; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; INFLAMMATION; LUTEINIZING HORMONE BLOOD LEVEL; PARAMETER; POSTMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEBORRHEA; SIDE EFFECT; SKIN; SKIN SURFACE; STATISTICAL SIGNIFICANCE; WRINKLE;

DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELASTICITY; ESTROGENS; FACE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; NECK; OINTMENTS; PROGESTERONE; SELF ASSESSMENT (PSYCHOLOGY); SKIN; SKIN ABSORPTION; SKIN AGING; STATISTICS, NONPARAMETRIC;

EID: 24344462716     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06685.x     Document Type: Article

References (33)

1. Fisher GJ, Kang S, Varani J et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138:1462-70.
2. Tan CY, Statham B, Marks R et al. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol 1982; 106:657-67.
3. Henry F, Pierard-Franchimont C, Cauwenbergh G et al. Age-related changes in facial skin contours and rheology. J Am Geriatr Soc 1997; 45:220-2.
4. Gilchrest BA. A review of skin ageing and its medical therapy. Br J Dermatol 1996; 135:867-75.
5. Sator PG, Schmidt JB, Sator MO et al. The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas 2001; 39:43-55.
6. Callens A, Vaillant L, Lecomte P et al. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology 1996; 193:289-94.
7. Brincat M, Moniz CF, Studd JW et al. Sex hormones and skin collagen content in postmenopausal women. Br Med J (Clin Res Ed) 1983; 287:1337-8.
8. Brincat M, Moniz CJ, Studd JW et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985; 92:256-9.
9. Pierard-Franchimont C, Letawe C, Goffin V et al. Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas 1995; 22:151-4.
10. Pierard GE, Letawe C, Dowlati A et al. Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995; 43:662-5.
11. Burry KA, Patton PE, Hermsmeyer K. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen. Am J Obstet Gynecol 1999; 180:1504-11.
12. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-33.
13. Grady D, Herrington D, Bittner V et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288:49-57.
14. Schmidt JB, Binder M, Macheiner W et al. Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot study. Maturitas 1994; 20:25-30.
15. Varila E, Rantala I, Oikarinen A et al. The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol 1995; 102:985-9.
16. Schmidt JB, Binder M, Demschik G et al. Treatment of skin aging with topical estrogens. Int J Dermatol 1996; 35:669-74.
17. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev 1997; 18:502-19.
18. Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990; 30:97-100.
19. Im S, Lee ES, Kim W et al. Expression of progesterone receptor in human keratinocytes. J Korean Med Sci 2000; 15:647-54.
20. Mercier I, Colombo F, Mader S et al. Ovarian hormones induce TGF-beta(3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovasc Res 2002; 53:728-39.
21. Hodgins MB, Spike RC, MacKie RM et al. An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol 1998; 105:216-22.
22. Tsukahara K, Takema Y, Moriwaki S et al. Carbon dioxide laser treatment promotes repair of the three-dimensional network of elastic fibres in rat skin. Br J Dermatol 2001; 144:452-8.
23. Koch RJ, Cheng ET. Quantification of skin elasticity changes associated with pulsed carbon dioxide laser skin resurfacing. Arch Facial Plast Surg 1999; 1:272-5.
24. Khalkhali-Ellis Z, Seftor EA, Nieva DR et al. Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis. J Rheumatol 2000; 27:1622-31.
25. Huber J, Gruber C. Immunological and dermatological impact of progesterone. Gynecol Endocrinol 2001; 15 (Suppl. 6):18-21.
26. Henriet P, Cornet PB, Lemoine P et al. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs). Ann NY Acad Sci 2002; 955:119-38.
27. Rittie L, Fisher GJ. UV-light-induced signal cascades and skin aging. Ageing Res Rev 2002; 1:705-20.
28. Uchiyama N, Yamamoto A, Kameda K et al. The activity of fatty acid synthase of epidermal keratinocytes is regulated in the lower stratum spinosum and the stratum basale by local inflammation rather than by circulating hormones. J Dermatol Sci 2000; 24:1134-41.
29. Simpson NB, Dick D, Hodgins MB. Effect of progesterone on sebum excretion rate. Br J Dermatol 1979; 100:735.
30. Schroder HG, Ziegler M, Nickisch K et al. Effects of topically applied antiandrogenic compounds on sebaceous glands of hamster ears and flank organs. J Invest Dermatol 1989; 92:769-73.
31. Orentreich N, Matias JR, Malloy V. The local antiandrogenic effect of the intracutaneous injection of progesterone in the flank organ of sexually mature male Syrian golden hamster. Arch Dermatol Res 1984; 276:401-5.
32. Dean HJ, Winter JS. The effect of five synthetic progestational compounds on 5 alpha-reductase activity in genital skin fibroblast monolayers. Steroids 1984; 43:13-24.
33. Carey BJ, Carey AH, Patel S et al. A study to evaluate serum and urinary hormone levels following short and long term administration of two regimens of progesterone cream in postmenopausal women. BJOG 2000; 107:722-6.